Edges in Network
| Network | GSE5851_top500tf - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | ARNT2 |
| Upstream (Parents) |
|---|
| (<<) MSX2 → ARNT2 |
| (<<) NR5A2 → ARNT2 |
| (<<) RUNX1T1 → ARNT2 |
| (<<) NR2E3 → ARNT2 |
| (<<) ZFPM2 → ARNT2 |
| (<<) TP53 → ARNT2 |
| (<<) SOX21 → ARNT2 |
| (<<) FLI1 → ARNT2 |
| (<<) SPI1 → ARNT2 |
| (<<) ZEB2 → ARNT2 |
| (<<) TFEC → ARNT2 |
| (<<) SATB1 → ARNT2 |
| (<<) ETV5 → ARNT2 |
| (<<) ETS1 → ARNT2 |
| (<<) MYOD1 → ARNT2 |
| (<<) ERG → ARNT2 |
| Downstream (Children) |
|---|
| ARNT2 → FOXE1 (>>) |
| ARNT2 → ST18 (>>) |
| ARNT2 → ZNF287 (>>) |
| ARNT2 → GSC2 (>>) |
| ARNT2 → PAX3 (>>) |
| ARNT2 → CSRNP3 (>>) |
| ARNT2 → PAX6 (>>) |
| ARNT2 → SOX10 (>>) |
| ARNT2 → SMAD3 (>>) |
| ARNT2 → PAX5 (>>) |
| ARNT2 → TFAP4 (>>) |
| ARNT2 → FOXH1 (>>) |
| ARNT2 → NR3C2 (>>) |
| ARNT2 → ZBTB48 (>>) |
| ARNT2 → CREB5 (>>) |
